ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 304421 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 304421; 2) Community: the network communities that were significantly associated with the response to NSC 304421; 3) Molecule: the relationships between components within communities and NSC 304421; 4) MDR: the compounds that were significantly associated with the NSC 304421.

NSC Compound Enrichment Correlation
NSC 701570 Androst-5-en-17-one, 3-acetyloxy-16-phenylmethylene-, 17-oxime, (3.beta.)- 0.0273093708703111 0.14510337
NSC 710272 Null 0.0273093708703111 0.13932289
NSC 10466 Aizen Magenta 0.0273093708703115 0.30807728
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0273093708703115 0.13174774
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0273093708703115 0.23989194
NSC 638788 2-N-Methyl-6-oxaellipticinium acetate 0.0273093708703115 0.31657306
NSC 639661 Null 0.0273093708703115 0.079811286
NSC 645158 Null 0.0273093708703115 0.27965136
NSC 662123 Null 0.0273093708703115 0.19790736
NSC 665128 Null 0.0273093708703115 0.10349552
Total:31  Current:15    [First] [Prev] [Next] [Last]